4/A//SEC Filing
Milligan Sandra 4/A
Accession 0001859810-25-000002
CIK 0000926617other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:20 PM ET
Size
9.7 KB
Accession
0001859810-25-000002
Insider Transaction Report
Form 4/AAmended
Milligan Sandra
Interim CEO
Transactions
- Exercise/Conversion
Common Stock
2024-12-31+20,000→ 20,000 total - Exercise/Conversion
Restricted Stock Units
2024-12-31+20,000→ 0 total→ Common Stock (20,000 underlying) - Tax Payment
Common Stock
2025-01-08$0.70/sh−6,356$4,449→ 13,644 total
Footnotes (5)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on October 28, 2024.
- [F2]This line reflects the tax withholding on the vesting of RSUs that vested on December 31, 2024.
- [F3]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
- [F4]On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.
- [F5]This report is being filed to correct the number of shares held after tax withholding on the vesting of RSUs that vested on December 31, 2024.
Documents
Issuer
Aspira Women's Health Inc.
CIK 0000926617
Entity typeother
Related Parties
1- filerCIK 0001859810
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 5:20 PM ET
- Size
- 9.7 KB